Show simple item record

dc.contributor.authorYee, NS
dc.contributor.authorNaing, AY
dc.contributor.authorCuesta, JG
dc.contributor.authorDas, M
dc.contributor.authorDave, K
dc.date.accessioned2020-07-16T15:25:53Z
dc.date.available2020-07-16T15:25:53Z
dc.date.issued2020-05-12
dc.date.submitted2020-07-10
dc.identifier.pmid32408591
dc.identifier.doi10.3390/tropicalmed5020077
dc.identifier.urihttp://hdl.handle.net/10144/619690
dc.description.abstractHepatitis B vaccination (HBV) is recommended for high-risk groups, such as people who inject drugs (PWIDs). As part of a harm reduction program by a non-governmental organization, hepatitis B screening, vaccination and antibody (HBAb) testing after completion of the vaccination schedule were offered to PWIDS in Myanmar. We determined the proportions of HBV non-completion and sero-unprotection among PWIDs enrolled in the program and their association with socio-demographic and clinical characteristics. We conducted a descriptive study based on routine program data in five selected clinics in Hpakant Township, Myanmar. PWIDs who were Hepatitis B antigen negative at screening during January 2015-December 2018 were included. Among 5386 participants eligible for HBV, 9% refused vaccination. Among those who accepted vaccination (n = 3177 individuals), 65% completed vaccination. Of those tested for HBsAb (n = 2202), 30% were sero-unprotected. Young-adults (aged 18-44 years) and migrant workers had a higher risk of incomplete vaccination. However, participants who used methadone had a lower risk of incomplete vaccination. Migrant workers had higher risk of not returning for HBsAb testing and HIV-positive participants had a higher risk of being HBV sero-unprotected. Efforts to increase HBV vaccination in PWIDs for young adults and clients during methadone and anti-retroviral services should be prioritized.en_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.rightsWith thanks to MDPI.en_US
dc.subjectSORT-IT
dc.subjecthepatitis B vaccination
dc.subjectpeople who inject drugs
dc.subjectsero-protection
dc.titleGaps in Hepatitis B Vaccination Completion and Sero-Protection for People Who Inject Drugs in Hpakant, Myanmar, 2015-2018en_US
dc.typeArticle
dc.identifier.eissn2414-6366
dc.identifier.journalTropical Medicine and Infectious Diseaseen_US
dc.source.journaltitleTropical medicine and infectious disease
dc.source.volume5
dc.source.issue2
refterms.dateFOA2020-07-16T15:25:53Z
dc.source.countrySwitzerland


Files in this item

Thumbnail
Name:
Yee et al 2020 Gaps in Hepatitis ...
Size:
553.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record